Key Insights
The China Continuous Glucose Monitoring (CGM) Devices market is experiencing robust growth, projected to reach \$505.13 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 10.39% from 2025 to 2033. This expansion is driven by several key factors. Firstly, the rising prevalence of diabetes in China, coupled with increasing awareness of the benefits of CGM technology for improved diabetes management, fuels significant demand. Secondly, advancements in CGM technology, including smaller, more comfortable devices with improved accuracy and longer battery life, are enhancing patient adoption. Government initiatives promoting better healthcare access and technological advancements in diabetes care also contribute to market growth. Key players like Abbott Diabetes Care, Dexcom Inc., and Medtronic PLC are driving innovation and market penetration, while domestic companies like Jiunuo Medical and Yuwell are capturing increasing market share. The market is segmented by components (sensors and durables), reflecting the diverse technological aspects of CGM devices. Competitive landscape analysis reveals a mix of established international players and growing domestic manufacturers vying for market share, leading to innovation and price competitiveness.
The forecast period (2025-2033) promises continued expansion, driven by the ongoing increase in diabetes prevalence, the expanding elderly population in China, and further technological refinements in CGM systems. However, challenges remain, such as high device costs, potentially limiting accessibility for a substantial portion of the population. Addressing this affordability issue through government subsidies or insurance coverage could further accelerate market growth. The market's future trajectory will be significantly influenced by the ongoing development and adoption of integrated diabetes management systems that combine CGM data with insulin delivery systems and remote monitoring capabilities. This convergence of technologies will likely reshape the competitive landscape and offer more comprehensive solutions for diabetes patients in China.

China Continuous Glucose Monitoring (CGM) Devices Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the dynamic China Continuous Glucose Monitoring (CGM) Devices market, offering invaluable insights for industry stakeholders, investors, and strategic decision-makers. Covering the period from 2019 to 2033, with a base year of 2025, this report meticulously examines market size, growth drivers, competitive landscape, and future opportunities. Expect detailed analysis of key players like Abbott Diabetes Care, Dexcom Inc., Medtronic PLC, Jiunuo Medical, Yuwell, GlySens, and Ascensia Diabetes Care, alongside a comprehensive "Other Company Share" analysis. The report segments the market by key components: Sensors and Durables. The projected market value is expected to reach xx Million by 2033.
China Continuous Glucose Monitoring Devices Market Market Dynamics & Concentration
The China CGM market exhibits a moderately concentrated structure, with key players like Abbott, Dexcom, and Medtronic holding significant market share. However, the emergence of domestic companies like Jiunuo Medical and Yuwell is steadily increasing competition. Innovation is a key driver, fueled by advancements in sensor technology, miniaturization, and data analytics capabilities. The regulatory landscape, while evolving, plays a crucial role in shaping market access and product approvals. Substitute products, such as traditional blood glucose meters, continue to exist, but the growing preference for continuous monitoring is driving market growth. End-user trends favor ease of use, accuracy, and integration with smart devices. The number of M&A activities in the sector has been relatively low in recent years with only xx deals recorded between 2019 and 2024, indicating a period of organic growth. Market share distribution among the top players shows a dynamic shift, with xx% held by Abbott, xx% by Dexcom, xx% by Medtronic and the remaining xx% shared amongst other players including domestic companies.
- Market Concentration: Moderately concentrated, with a shift towards increased competition from domestic players.
- Innovation Drivers: Advancements in sensor technology, miniaturization, and data analytics.
- Regulatory Framework: Evolving regulatory landscape impacting market access and approvals.
- Product Substitutes: Traditional blood glucose meters.
- End-User Trends: Preference for ease of use, accuracy, and integration with smart devices.
- M&A Activities: Relatively low number of deals between 2019-2024, reflecting organic growth.
China Continuous Glucose Monitoring Devices Market Industry Trends & Analysis
The China CGM market is experiencing robust growth, driven by increasing diabetes prevalence, rising awareness of continuous glucose monitoring benefits, and improving healthcare infrastructure. The CAGR for the forecast period (2025-2033) is estimated at xx%. Technological disruptions, such as the development of non-invasive monitoring technologies, promise to revolutionize the market. Consumer preferences are shifting towards smaller, more user-friendly devices with advanced features. Competitive dynamics are characterized by a mix of established multinational corporations and emerging domestic players, leading to price competition and innovation. Market penetration is currently at xx% and is projected to reach xx% by 2033 due to the factors mentioned.

Leading Markets & Segments in China Continuous Glucose Monitoring Devices Market
The report identifies xx as the leading region/province within the China CGM market, primarily due to higher diabetes prevalence rates and well-established healthcare infrastructure. The sensor segment dominates the component market, driven by the continuous need for replacement sensors.
- Key Drivers for Dominant Region (xx):
- High prevalence of diabetes
- Advanced healthcare infrastructure
- Government initiatives supporting diabetes management
- Dominance Analysis: The report provides a detailed analysis of the factors contributing to the dominance of the xx region and the Sensor segment, considering various economic and market parameters.
China Continuous Glucose Monitoring Devices Market Product Developments
Recent product developments highlight a clear trend towards smaller, more comfortable sensors, improved accuracy, and longer sensor lifespan. Wireless connectivity and data integration with smartphones and other devices are becoming standard features. These advancements aim to improve patient compliance and enhance the overall user experience, making CGMs more accessible and appealing to a broader patient population.
Key Drivers of China Continuous Glucose Monitoring Devices Market Growth
The market is propelled by several key factors: the rising prevalence of diabetes in China, increasing government support for diabetes management programs, technological advancements leading to improved accuracy and usability of CGM devices, and growing consumer awareness of the benefits of continuous glucose monitoring. These factors collectively contribute to the significant growth potential of the China CGM market.
Challenges in the China Continuous Glucose Monitoring Devices Market Market
Key challenges include the high cost of CGM devices, which limits accessibility for a significant portion of the population. Regulatory hurdles and reimbursement policies can also impact market penetration. Furthermore, the intensity of competition from both established international players and emerging domestic companies creates a challenging environment. These combined challenges account for a xx% reduction in market growth in the early years of the study period.
Emerging Opportunities in China Continuous Glucose Monitoring Devices Market
Emerging opportunities stem from the development of non-invasive CGM technologies, strategic partnerships between domestic and international players, and the expansion of CGM use into broader patient populations. Growing government initiatives focused on improving diabetes care also create significant opportunities for market growth and expansion.
Leading Players in the China Continuous Glucose Monitoring Devices Market Sector
- Abbott Diabetes Care
- Dexcom Inc.
- Medtronic PLC
- Other Company Share Analyse
- Jiunuo Medical
- Yuwell
- GlySens
- Ascensia Diabetes Care
Key Milestones in China Continuous Glucose Monitoring Devices Market Industry
- November 2023: SIBIONICS receives CE Mark for its GS1 CGM, expanding market access in Europe. This event will likely contribute to the increase of market size in the coming years.
- June 2023: Know Labs aims to launch a non-invasive glucose monitor, potentially disrupting the market if successful. This non-invasive technology is predicted to influence the market share of different players once available commercially.
Strategic Outlook for China Continuous Glucose Monitoring Devices Market Market
The China CGM market holds significant potential for continued growth, driven by technological advancements, favorable government policies, and increasing awareness of diabetes management. Strategic partnerships and expansion into underserved markets will be key success factors for companies in this sector. The market is poised for further consolidation and innovation in the coming years.
China Continuous Glucose Monitoring Devices Market Segmentation
-
1. Component
- 1.1. Sensors
- 1.2. Durables
China Continuous Glucose Monitoring Devices Market Segmentation By Geography
- 1. China

China Continuous Glucose Monitoring Devices Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 10.39% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rapidly Increasing Incidence and Prevalence of Diabetes; Technological Advancements in the Market
- 3.3. Market Restrains
- 3.3.1. Monopolized Supply Chain and High Cost of Devices
- 3.4. Market Trends
- 3.4.1. Rising Diabetes Prevalence in China
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. China Continuous Glucose Monitoring Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Component
- 5.1.1. Sensors
- 5.1.2. Durables
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. China
- 5.1. Market Analysis, Insights and Forecast - by Component
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Abbott Diabetes Care
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Dexcom Inc
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Medtronic PLC
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Other Company Share Analyse
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Jiunuo Medical
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Yuwell
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 GlySens
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Ascensia Diabetes Care
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.1 Abbott Diabetes Care
List of Figures
- Figure 1: China Continuous Glucose Monitoring Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: China Continuous Glucose Monitoring Devices Market Share (%) by Company 2024
List of Tables
- Table 1: China Continuous Glucose Monitoring Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: China Continuous Glucose Monitoring Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: China Continuous Glucose Monitoring Devices Market Revenue Million Forecast, by Component 2019 & 2032
- Table 4: China Continuous Glucose Monitoring Devices Market Volume K Unit Forecast, by Component 2019 & 2032
- Table 5: China Continuous Glucose Monitoring Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 6: China Continuous Glucose Monitoring Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 7: China Continuous Glucose Monitoring Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 8: China Continuous Glucose Monitoring Devices Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 9: China Continuous Glucose Monitoring Devices Market Revenue Million Forecast, by Component 2019 & 2032
- Table 10: China Continuous Glucose Monitoring Devices Market Volume K Unit Forecast, by Component 2019 & 2032
- Table 11: China Continuous Glucose Monitoring Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: China Continuous Glucose Monitoring Devices Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the China Continuous Glucose Monitoring Devices Market?
The projected CAGR is approximately 10.39%.
2. Which companies are prominent players in the China Continuous Glucose Monitoring Devices Market?
Key companies in the market include Abbott Diabetes Care, Dexcom Inc, Medtronic PLC, Other Company Share Analyse, Jiunuo Medical, Yuwell, GlySens, Ascensia Diabetes Care.
3. What are the main segments of the China Continuous Glucose Monitoring Devices Market?
The market segments include Component.
4. Can you provide details about the market size?
The market size is estimated to be USD 505.13 Million as of 2022.
5. What are some drivers contributing to market growth?
Rapidly Increasing Incidence and Prevalence of Diabetes; Technological Advancements in the Market.
6. What are the notable trends driving market growth?
Rising Diabetes Prevalence in China.
7. Are there any restraints impacting market growth?
Monopolized Supply Chain and High Cost of Devices.
8. Can you provide examples of recent developments in the market?
November 2023: SIBIONICS, a Chinese company, announced that it received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, facilitating the distribution and utilization of this game-changing technology throughout the European market.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "China Continuous Glucose Monitoring Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the China Continuous Glucose Monitoring Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the China Continuous Glucose Monitoring Devices Market?
To stay informed about further developments, trends, and reports in the China Continuous Glucose Monitoring Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence